Please use this identifier to cite or link to this item:
Title: Hepatitis B and NAFLD: Lives Crossed.
Authors: Morales, María L
Sendra, Carmen
Romero-Gomez, Manuel
Keywords: HBeAg;HBsAg;Hepatitis B;NAFLD;NASH
metadata.dc.subject.mesh: Hepatitis B
Hepatitis B Surface Antigens
Hepatitis B virus
Hepatitis B, Chronic
Non-alcoholic Fatty Liver Disease
Issue Date: 2017
Abstract: Hepatitis B virus infection seems to protect against steatosis and insulin resistance decreasing NAFLD. Metabolic syndrome has been associated with increased risk of disease progression to cirrhosis and liver cancer in hepatitis B. HBsAg seroclearance increased over time and it could be a confounding factor when analysing NAFLD and hepatitis B prevalence.
metadata.dc.identifier.doi: 10.5604/16652681.1231556
ISSN: 1665-2681
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons